Serial Number
97830057
Owner
Apexcella Biomedical Inc.Attorney
Joseph A. BruceFiling Date
Mar 9, 2023
APEXNK Trademark
Serial Number: 97830057
Trademark Classes
Owner Contact Info
17 F., No. 3, Yuanqu St., Nangang Dist.,
Taipei City 115603 , TW
Entity Type: 03
Legal Representation
Correspondence Address
Joseph A. Bruce BRUCE STONE LLP
8888 KEYSTONE CROSSING, SUITE 1300
INDIANAPOLIS, IN 46240
United States
Trademark Details
Filing Date
March 9, 2023
Registration Date
Not Registered
Published for Opposition
April 2, 2024
Goods & Services
Biological research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Research and development in the pharmaceutical and biotechnology fields; Medical research services; Medical research and development in the field of cancer immunotherapy; Research and development of new products for others; Technological research in the field of cancer immunotherapy; Conducting technical project studies in the nature of scientific feasibility studies; Technical writing for others; Scientific laboratory services; Scientific research; Technological consultancy services in the field of cancer immunotherapy; Scientific and technological research relating to cancer immunotherapy; Culturing of cells for others for scientific research purposes; New product design services; Packaging design; Graphic design services; Custom design of prototypes; Graphic design of logos; Quality control of goods and services; Product quality testing services
Immunostimulants; Pre-filled cell-based medicinal products, namely, medicinal products for aging, oncology and autoimmune disease; Biological tissue cultures for medical purposes; Anti-cancer preparations; Medicines for the treatment of cancer; Active pharmaceutical ingredient for western medicine, namely, pharmaceutical agents for aging, oncology and autoimmune disease; Anti-cancer agents; Antivirals; Biological preparations for the treatment of cancer; Biocides; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer treatment; Blood for medical purposes; Adjuvants for medical purposes; Albuminous preparations for medical purposes; Pharmaceuticals, namely, immunotherapy being immunostimulators; Pharmaceutical preparations for the treatment of cancer; Stem cells for medical purposes; Reagents for medical use; Diagnostic reagents for medical use
